Generic Name
Sulindac
FDA approval date: April 03, 1990
Classification: Nonsteroidal Anti-inflammatory Drug
Form: Tablet
What is Sulindac?
Carefully consider the potential benefits and risks of sulindac tablets and other treatment options before deciding to use sulindac tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. Sulindac tablets are indicated for acute or long-term use in the relief of signs and symptoms of the following: 1. Osteoarthritis 2. Rheumatoid arthritis* 3. Ankylosing spondylitis 4. Acute painful shoulder 5. Acute gouty arthritis.
Top Global Experts
There are no experts for this drug
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment
Related Latest Advances
There is no latest advances for this treatment